To improve transparency and the availability of information regarding dietary supplements by amending the Federal Food, Drug, and Cosmetic Act to require manufacturers of dietary supplements to list dietary supplements with the Food and Drug Administration.
About This Bill
Committee
Latest Action · July 29, 2024
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S5552-5553)
The Dietary Supplement Listing Act of 2024 requires manufacturers of dietary supplements to register their products with the FDA and submit detailed information about each supplement they sell. Manufacturers must provide the FDA with the supplement's name, ingredients, amounts, directions for use, warnings, allergen information, health claims, and a copy of the product label. This requirement applies to dietary supplements already on the market by January 1, 2025, with an 18-month deadline to submit listings, while new supplements must be registered at the time they enter the market. The FDA will create a publicly searchable database containing this information within two years of the law's enactment, though some confidential business details will be withheld. The legislation authorizes approximately $7.9 million for fiscal year 2024 and $6.6 million annually through 2028 to implement these requirements.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.